Andrew Hindman
2017
In 2017, Andrew Hindman earned a total compensation of $1.6M as Chief Business Officer at Acorda Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $125,543 |
| Option Awards | $641,903 |
| Salary | $463,950 |
| Stock Awards | $315,963 |
| Other | $7,950 |
| Total | $1,605,309 |
Hindman received $641.9K in option awards, accounting for 40% of the total pay in 2017.
Hindman also received $50K in bonus, $125.5K in non-equity incentive plan, $464K in salary, $316K in stock awards and $8K in other compensation.
Rankings
In 2017, Andrew Hindman's compensation ranked 6,630th out of 14,666 executives tracked by ExecPay. In other words, Hindman earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,630 out of 14,666 | 55th |
Division Manufacturing | 2,453 out of 5,772 | 58th |
Major group Chemicals And Allied Products | 789 out of 2,075 | 62nd |
Industry group Drugs | 609 out of 1,731 | 65th |
Industry Biological Products, Except Diagnostic Substances | 111 out of 313 | 65th |
Source: SEC filing on April 27, 2018.
Hindman's colleagues
We found five more compensation records of executives who worked with Andrew Hindman at Acorda Therapeutics in 2017.
2017
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2017
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2017
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2017
Jane Wasman
Acorda Therapeutics
General Counsel
2017
David Lawrence
Acorda Therapeutics